MSCI is reviewing Indian companies, leading to potential upgrades and removal risks for stocks like SBI Cards, Biocon, and Laurus Labs.
Steady: 1 in the last 7 days
Updated friday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MSCI is reviewing Indian companies, leading to potential upgrades and removal risks for stocks like SBI Cards, Biocon, and Laurus Labs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- SBI Cards has been operating in the competitive Indian credit card market since March 9, 2026.Sub-event
- MSCI rebalancing test affects Indian markets.Sub-event
- MSCI is reviewing Indian companies, with high probability for inclusion in the MSCI India Standard Index for several firms.Sub-event
- MSCI India Standard Index review drives fund flows.Sub-event
MSCI index review drives fund flows and potential upgrades/removals for Indian stocks.1 source
Biocon is a candidate for index upgrade.1 source
Keep exploring
The entities involved
-
MSCI
American financial service provider
-
SBI Cards
Payment solutions provider in India
Nothing else this week.
-
Biocon
an Indian biopharmaceutical company
Nothing else this week.
-
Laurus Labs
Indian pharmaceutical company
Related events
- MSCI indexes are now under the oversight of the Indian market regulator.
- MSCI index rules may affect Bitcoin companies, while warnings caused stock market crashes in Turkey and Indonesia.
- SEBI oversees market mechanisms in India, including the successful CAS rebalancing praised by MSCI.
- MSCI tracks Asia-Pacific shares and issues warnings affecting regional market sentiment, including Bursa Malaysia and Singapore.